New treatments for small cell lung cancer
Novel therapeutic development for small cell lung cancer
This research aims to find new and better ways to treat small cell lung cancer, a fast-growing and aggressive type of lung cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11137569 on NIH RePORTER |
What this research studies
Our team has spent over two decades dedicated to understanding small cell lung cancer, from basic discoveries to testing new treatments in patients. We are working to understand the unique features of these tumors, including different types of cells within them and how they interact with the body's immune system. By identifying specific stem-like cells that contribute to the cancer's spread and a particular type of immune cell found in these tumors, we hope to develop more effective therapies. Our goal is to translate these laboratory findings into new options for patients.
Who could benefit from this research
Good fit: This research is focused on understanding and treating small cell lung cancer, so it is most relevant to patients diagnosed with this specific condition.
Not a fit: Patients without small cell lung cancer would not directly benefit from the specific treatments or insights developed through this particular research.
Why it matters
Potential benefit: If successful, this work could lead to the development of innovative and more effective treatments for patients with small cell lung cancer, potentially improving their prognosis.
How similar studies have performed: This laboratory has a strong track record of translating discoveries into clinical trials, with many active trials currently underway based on their previous findings.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Rudin, Charles M. — Sloan-Kettering Inst Can Research
- Study coordinator: Rudin, Charles M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.